Comparison of blast percentage calculated based on bone marrow all nucleated cells and non-erythroid cells in myelodysplastic syndromes with erythroid hyperplasia.
Mashima K, Ikeda T, Kawaguchi SI, Toda Y, Ito S, Ochi SI, Nagayama T, Umino K, Minakata D, Nakano H, Yamasaki R, Morita K, Kawasaki Y, Sugimoto M, Ishihara Y, Ashizawa M, Yamamoto C, Fujiwara SI, Hatano K, Sato K, Oh I, Ohmine K, Muroi K, Kanda Y.
Mashima K, et al. Among authors: kanda y.
Ann Hematol. 2019 May;98(5):1127-1133. doi: 10.1007/s00277-018-3560-x. Epub 2018 Nov 24.
Ann Hematol. 2019.
PMID: 30474718
Clinical Trial.